RHODES JASON P sold 8.6% of their position (106.72K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.94M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−3.14K
Price / share
$18.00
Trade value
$56.45K
% of position
Common Stock
Shares
−6.24K
Price / share
$18.00
Trade value
$112.34K
% of position
Common Stock
Shares
−61.00
Price / share
$18.00
Trade value
$1.10K
% of position
Common Stock
Shares
−2.47K
Price / share
$18.00
Trade value
$44.39K
% of position
Common Stock
Shares
−3.06K
Price / share
$18.03
Trade value
$55.10K
% of position
Common Stock
Shares
−6.08K
Price / share
$18.03
Trade value
$109.64K
% of position
Common Stock
Shares
−60.00
Price / share
$18.03
Trade value
$1.08K
% of position
Common Stock
Shares
−2.40K
Price / share
$18.03
Trade value
$43.33K
% of position
Common Stock
Shares
−21.93K
Price / share
$18.18
Trade value
$398.61K
% of position
Common Stock
Shares
−43.62K
Price / share
$18.18
Trade value
$793.03K
% of position
Common Stock
Shares
−428.00
Price / share
$18.18
Trade value
$7.78K
% of position
Common Stock
Shares
−17.24K
Price / share
$18.18
Trade value
$313.50K
% of position
Net shares
−106.72K
Net value
-$1.94M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/4/2026 | S · Sale | −3.14K | $18.00 | $56.45K | 0.2% | 1.58M | 1.57M |
| Common Stock Indirect | 5/4/2026 | S · Sale | −6.24K | $18.00 | $112.34K | 0.1% | 4.94M | 4.93M |
| Common Stock Indirect | 5/4/2026 | S · Sale | −61.00 | $18.00 | $1.10K | 0.7% | 8.51K | 8.45K |
| Common Stock Indirect | 5/4/2026 | S · Sale | −2.47K | $18.00 | $44.39K | 0.2% | 1.16M | 1.16M |
| Common Stock Indirect | 5/5/2026 | S · Sale | −3.06K | $18.03 | $55.10K | 0.2% | 1.57M | 1.57M |
| Common Stock Indirect | 5/5/2026 | S · Sale | −6.08K | $18.03 | $109.64K | 0.1% | 4.93M | 4.93M |
| Common Stock Indirect | 5/5/2026 | S · Sale | −60.00 | $18.03 | $1.08K | 0.7% | 8.45K | 8.39K |
| Common Stock Indirect | 5/5/2026 | S · Sale | −2.40K | $18.03 | $43.33K | 0.2% | 1.16M | 1.15M |
| Common Stock Indirect | 5/6/2026 | S · Sale | −21.93K | $18.18 | $398.61K | 1.4% | 1.57M | 1.55M |
| Common Stock Indirect | 5/6/2026 | S · Sale | −43.62K | $18.18 | $793.03K | 0.9% | 4.93M | 4.88M |
| Common Stock Indirect | 5/6/2026 | S · Sale | −428.00 | $18.18 | $7.78K | 5.1% | 8.39K | 7.96K |
| Common Stock Indirect | 5/6/2026 | S · Sale | −17.24K | $18.18 | $313.50K | 1.5% | 1.15M | 1.14M |
| Total | −106.72K | -$1.94M | ||||||